1-4 of 4
Xiaochun Li, PhD
Close
Sort by
Journal Articles

Prolonged Low Dose Therapy with a Pan-Deacetylase Inhibtor, Panobinostat (LBH589), in Patients with Myelofibrosis

John Mascarenhas, MD, Alice Mercado, RN, Amelyn Rodriguez, BSN, RN, OCN, Min Lu, PhD, Carla Kalvin, Xiaochun Li, PhD, Bruce Petersen, MD, Vesna Najfeld, PhD, Judith D. Goldberg, Sc.D., Ronald Hoffman, MD
Journal: Blood
Blood (2011) 118 (21): 794.
https://doi.org/10.1182/blood.V118.21.794.794
Published: 2011
Journal Articles

A Randomized, Placebo-Controlled, Double Blind Trial of the MDR Modulator, Zosuquidar, during Conventional Induction and Post-Remission Therapy for Pts > 60 Years of Age with Newly Diagnosed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (HR-MDS): ECOG 3999.

Larry D. Cripe, MD, Xiaochun Li, PhD, Mark Litzow, MD, Elisabeth Paietta, Jacob M. Rowe, MD, Selina Luger, MD, Martin Tallman, MD
Journal: Blood
Blood (2006) 108 (11): 423.
https://doi.org/10.1182/blood.V108.11.423.423
Published: 2006
Journal Articles

A Molecular Signature of the Transcription Factor GATA1 in Acute Megakaryoblastic Leukemia of Childhood.

Jean-Pierre Bourquin, MD-PhD, Claudia Langebrake, PharmD, Aravind Subramanian, PhD, Xiaochun Li, PhD, Dirk Reinhardt, MD, Olivier Bernard, MD, Christian M. Zwaan, MD-PhD, Henrik Hasle, MD, Martin Schrappe, MD, Todd R. Golub, MD, Stuart H. Orkin, MD
Journal: Blood
Blood (2004) 104 (11): 1117.
https://doi.org/10.1182/blood.V104.11.1117.1117
Published: 2004
Journal Articles

Identification of a LOH Region on Chromosome 9p Associated with a Specific Gene Expression Signature in Adult B-Lineage ALL through Integration of High Density Microarray Expression and SNP Analyses.

Sabina Chiaretti, MD, Xiaochun Li, PhD, Robert Gentleman, PhD, Cheng Li, PhD, Antonella Vitale, MD, Marco Mancini, MD, Cristina Mecucci, MD, Robin Foa, MD, Jerome Ritz, MD
Journal: Blood
Blood (2004) 104 (11): 1119.
https://doi.org/10.1182/blood.V104.11.1119.1119
Published: 2004